SUPPLIVER: Bioartificial supply for liver failure

IRBM

Volumn 36, Issue 2, 2015, Pages 101-109

  Figaro, S ^a,b   Pereira, U ^a   Dume A S ^d   Rada, H ^b   Capone, S ^c,d   Bengrine, A ^e   Baze, A ^f   Rabenirina, E ^f   Semenzato, N ^b   Herpe, Y E ^e   Faivre, J ^c   Dufresne, M ^a   Richert, L ^f   Duverlie, G ^e   Daujat Chavanieu, M ^d   Saliba, F ^c   Pouchoulin, D ^b   Legallais, C ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b Research Center   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d INSERM   (France)

^e Biobanque de Picardie   (France)

^f Research and Development   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID;

ANIMAL CELL; BIOARTIFICIAL LIVER; BIOREACTOR; CELL ENCAPSULATION; CONFERENCE PAPER; EX VIVO STUDY; FLUIDIZATION; FLUIDIZED BED REACTOR; GELATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; MALE; MONITORING; NONHUMAN; OVINE MODEL; PLASMAPHERESIS; RAT; SPHEROID CELL;

OVIS ARIES;

EID: 84924249448     PISSN: 19590318     EISSN: 18760988     Source Type: Journal    
DOI: 10.1016/j.irbm.2015.01.010     Document Type: Conference Paper

References (12)

1. Bhatia SN, Balis UJ, Yarmush ML, Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FAS E B J 1999;13:1883-900.
2. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, et al. CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014;61(5):1038-47.
3. Larson AM, Polson J, Fontana RJ, et al. Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364-72.
4. Agence de Biomédecine. Greffe hépatique Bilan 2013. http://www.agence-biomedecine.fr/annexes/bilan2013/donnees/organes/05-foie/pdf/hepatique.pdf.
5. Eurotransplant International Foundation. Annual report. 2013. Available from: www.eurotransplant.org/cms/mediaobject.php?file=AR20135.pdf.
6. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut 2009;58:1690-702.
7. Gautier A, Carpentier B, Dufresne M, Vu Dinh Q, Paullier P, Legallais C. Impact of alginate type and bead diameter on activities of encapsulated C3A cells for bioartificial liver applications. Eur Cell Mater 2011;21:94-106.
8. Schwartz RE, Fleming HE, Khetani SR, Bhatia SN. Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 2014;32(2):504-13.
9. Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, et al. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology 2014;60(2):700-14.
10. Capone S. Encapsulation d'hépatocytes dans un biomateriau poreux en vue d'une implantation dans un modèle animal. PhD thesis, Edt UTC, Université de Technologie de Compiègne, 2012, National number 2012COMP2033.
11. Moniaux N, Song H, Darnaud M, Garbin K, Gigou M, Mitchell C, et al. Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers. Hepatology 2011;53(2):618-27.
12. David B, Barbe L, Legallais C, Barthès-Biesel D. Mechanical properties of alginate beads hosting hepatocytes in a fluidized bed bioreactor. Int J Artif Organs 2006;29(8):756-63.